ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
69.89
-2.02 (-2.81%)
At close: Aug 13, 2025, 4:00 PM
69.50
-0.39 (-0.56%)
After-hours: Aug 13, 2025, 7:58 PM EDT
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
$165,855
Profits / Employee
-$2,909,594
Market Cap
5.29B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ABVX News
- 16 days ago - Abivax Announces Closing of $747.5 Million Public Offering - GlobeNewsWire
- 20 days ago - Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) - GlobeNewsWire
- 20 days ago - Abivax: Positive Obefazimod Induction Data Leads To Next 44-Week Maintenance Trial Catalyst - Seeking Alpha
- 20 days ago - Abivax announces trading resumption of its ordinary shares on Euronext Paris - GlobeNewsWire
- 20 days ago - Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares - GlobeNewsWire
- 21 days ago - Abivax announces temporary trading halt of its ordinary shares on Euronext Paris - GlobeNewsWire
- 21 days ago - Abivax Announces Launch of Public Offering - GlobeNewsWire
- 21 days ago - Abivax: Differentiated Phase 3 Data Ignites A Multi-Billion Dollar Opportunity - Seeking Alpha